Review



human hcc cell lines hepg2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC human hcc cell lines hepg2
    Human Hcc Cell Lines Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 31345 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hcc cell lines hepg2/product/ATCC
    Average 99 stars, based on 31345 article reviews
    human hcc cell lines hepg2 - by Bioz Stars, 2026-02
    99/100 stars

    Images



    Similar Products

    human hcc cell lines hepg2  (ATCC)
    99
    ATCC human hcc cell lines hepg2
    Human Hcc Cell Lines Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hcc cell lines hepg2/product/ATCC
    Average 99 stars, based on 1 article reviews
    human hcc cell lines hepg2 - by Bioz Stars, 2026-02
    99/100 stars
    		  Buy from Supplier
    human hcc cell line hepg2  (ATCC)
    99
    ATCC human hcc cell line hepg2
    Antitumor effects of SIT and combined treatment on HCC cells. <t>HepG2</t> cells (A) and Hepa1–6 cells (B) were administrated SIT, sorafenib, and sorafenib + SIT at serial concentrations, and Cell Counting Kit-8 (CCK-8) assays were used to determine the cell viability. HepG2 cells (C) and Hepa1–6 cells (D) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and cell proliferation was evaluated using the 5-ethynyl-29-deoxyuridine (EdU) assay. HepG2 cells (E) and Hepa1–6 cells (F) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and cell apoptosis induction was evaluated using flow cytometry. Hepa1–6 cells (G) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and vasculogenic mimicry (VM) formation was evaluated in three-dimensional culture. Data were presented as mean ± SEM, n = 3, One-way ANOVA. * p < .05; ** p < .01; *** p < .001; and **** p < .0001.
    Human Hcc Cell Line Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hcc cell line hepg2/product/ATCC
    Average 99 stars, based on 1 article reviews
    human hcc cell line hepg2 - by Bioz Stars, 2026-02
    99/100 stars
    		  Buy from Supplier
    isolation 132 human hcc hepg2 cell lines  (ATCC)
    99
    ATCC isolation 132 human hcc hepg2 cell lines
    Antitumor effects of SIT and combined treatment on HCC cells. <t>HepG2</t> cells (A) and Hepa1–6 cells (B) were administrated SIT, sorafenib, and sorafenib + SIT at serial concentrations, and Cell Counting Kit-8 (CCK-8) assays were used to determine the cell viability. HepG2 cells (C) and Hepa1–6 cells (D) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and cell proliferation was evaluated using the 5-ethynyl-29-deoxyuridine (EdU) assay. HepG2 cells (E) and Hepa1–6 cells (F) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and cell apoptosis induction was evaluated using flow cytometry. Hepa1–6 cells (G) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and vasculogenic mimicry (VM) formation was evaluated in three-dimensional culture. Data were presented as mean ± SEM, n = 3, One-way ANOVA. * p < .05; ** p < .01; *** p < .001; and **** p < .0001.
    Isolation 132 Human Hcc Hepg2 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/isolation 132 human hcc hepg2 cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    isolation 132 human hcc hepg2 cell lines - by Bioz Stars, 2026-02
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Antitumor effects of SIT and combined treatment on HCC cells. HepG2 cells (A) and Hepa1–6 cells (B) were administrated SIT, sorafenib, and sorafenib + SIT at serial concentrations, and Cell Counting Kit-8 (CCK-8) assays were used to determine the cell viability. HepG2 cells (C) and Hepa1–6 cells (D) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and cell proliferation was evaluated using the 5-ethynyl-29-deoxyuridine (EdU) assay. HepG2 cells (E) and Hepa1–6 cells (F) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and cell apoptosis induction was evaluated using flow cytometry. Hepa1–6 cells (G) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and vasculogenic mimicry (VM) formation was evaluated in three-dimensional culture. Data were presented as mean ± SEM, n = 3, One-way ANOVA. * p < .05; ** p < .01; *** p < .001; and **** p < .0001.

    Journal: Translational Oncology

    Article Title: β-Sitosterol enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma via the FXR/LXR/ SREBP1/ FASN pathway

    doi: 10.1016/j.tranon.2025.102610

    Figure Lengend Snippet: Antitumor effects of SIT and combined treatment on HCC cells. HepG2 cells (A) and Hepa1–6 cells (B) were administrated SIT, sorafenib, and sorafenib + SIT at serial concentrations, and Cell Counting Kit-8 (CCK-8) assays were used to determine the cell viability. HepG2 cells (C) and Hepa1–6 cells (D) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and cell proliferation was evaluated using the 5-ethynyl-29-deoxyuridine (EdU) assay. HepG2 cells (E) and Hepa1–6 cells (F) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and cell apoptosis induction was evaluated using flow cytometry. Hepa1–6 cells (G) were treated with SIT (2 μM), sorafenib (10 μM) or a combination of both, and vasculogenic mimicry (VM) formation was evaluated in three-dimensional culture. Data were presented as mean ± SEM, n = 3, One-way ANOVA. * p < .05; ** p < .01; *** p < .001; and **** p < .0001.

    Article Snippet: The human HCC cell line HepG2 and the murine HCC cell line Hepa1–6 was purchased from the American Type Culture Collection.

    Techniques: Cell Counting, CCK-8 Assay, EdU Assay, Flow Cytometry